NCT01670409View on ClinicalTrials.gov

Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Esophageal Neoplasms
Interventions
RADIATION

SMART

The PTV (planning target volume) of gross tumor will receive radiation dose of 66Gy, 2.2Gy per fraction and the PTV of subclinical disease will receive 54Gy, 1.8Gy per fraction,5 fraction per week.

DRUG

PF

Concurrent and adjuvant chemotherapy: Cisplatin, 80mg/m2, intravenous on day 1, 5fluorouracil 0.5/m2, intravenous on d1 to d4. Two cycles during radiation treatment on d1 and d28. Two additional cycles after radiation treatment, 4 weeks per cycle.

Trial Locations (1)

515031

Cancer Hospital, Shantou University Medical College, Shantou

All Listed Sponsors
lead

Chuangzhen Chen

OTHER

NCT01670409 - Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal Cancer | Biotech Hunter | Biotech Hunter